Medecine & DroitPub Date : 2024-07-26DOI: 10.1016/j.meddro.2024.05.003
Pierre Jouannet
{"title":"À propos du diagnostic préimplantatoire des aneuploïdies (DPI-A). Les inconvénients de mots inappropriés et d’une réglementation inadaptée","authors":"Pierre Jouannet","doi":"10.1016/j.meddro.2024.05.003","DOIUrl":"10.1016/j.meddro.2024.05.003","url":null,"abstract":"<div><div>Finding biological markers to assess the ability of embryos to develop is a major objective of research being carried out to improve the results of in vitro fertilization (IVF). Among these markers, the chromosomal content of embryonic cells has been the subject of numerous studies to identify euploid embryos which will be transferred as a priority into the uterus. In France, a clinical research program funded by the Ministry of Health was undertaken to evaluate the benefit of this strategy when IVF is carried out in women aged 35 to 41. This program was interrupted because its authorization was canceled by a court on the grounds that the search for aneuploidy in the embryo is a preimplantation genetic diagnosis (PGD) and that this type of analysis is not provided for in the governing law. The law says in fact that a PGD can only be carried out if “<em>has been previously and precisely identified, in one of the parents or one of their immediate ascendants in the case of a seriously disabling illness, with late revelation and prematurely endangering the vital prognosis</em>”. But the chromosomal analysis provided for in the research protocol is not a diagnosis, it is a test which identifies the embryos most capable of developing. Like all other techniques with the same goal, this test is not the responsibility of the law but of the good practice guide. Studies seeking to improve the results of IVF for the benefit of couples who use it should not be prevented.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2024 188","pages":"Pages 83-86"},"PeriodicalIF":0.1,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141849569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medecine & DroitPub Date : 2024-07-19DOI: 10.1016/j.meddro.2024.07.001
Valérie Siranyan (professeure de droit pharmaceutique et d’économie de la santé) , Mathieu Guerriaud (maître de conférences en droit pharmaceutique et de la santé, pharmacovigilance et iatrogénie)
{"title":"Prescription et dispensation de médicaments en dehors des recommandations du dossier d’autorisation de mise sur le marché. Responsabilités des praticiens. L’exemple des fluoroquinolones","authors":"Valérie Siranyan (professeure de droit pharmaceutique et d’économie de la santé) , Mathieu Guerriaud (maître de conférences en droit pharmaceutique et de la santé, pharmacovigilance et iatrogénie)","doi":"10.1016/j.meddro.2024.07.001","DOIUrl":"10.1016/j.meddro.2024.07.001","url":null,"abstract":"<div><div>Some complaints were filed in 2023 by several patients, victims of serious adverse effects related to treatment with fluoroquinolones. These procedures thus raise questions about the possible consequences of the choice to prescribe and dispense therapeutics outside the recommendations of the indications in the marketing authorization dossier and the health safety agencies. In terms of indemnity liability, prescribing and dispensing antibiotic therapy require to explain potentially serious adverse events such as tendinopathy or neuropsychic impairment, in the respect of law. In this case, the decision to undertake a therapy that is not completely proven or that presents significant health risks will involve to consider all available options, on the basis of clinical documentation validated and recognized by the entire scientific community.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2024 188","pages":"Pages 98-102"},"PeriodicalIF":0.1,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141850281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medecine & DroitPub Date : 2024-07-14DOI: 10.1016/j.meddro.2024.06.001
Ridouan Hammouch Professeur Maître de Conférence - Docteur en Droit Privé , Yamna Fatmi Professeure universitaire - P.E.S.
{"title":"La rigueur scientifique de l’approche expertale","authors":"Ridouan Hammouch Professeur Maître de Conférence - Docteur en Droit Privé , Yamna Fatmi Professeure universitaire - P.E.S.","doi":"10.1016/j.meddro.2024.06.001","DOIUrl":"10.1016/j.meddro.2024.06.001","url":null,"abstract":"<div><div>Experts are crucial in legal disputes that involve technical matters beyond a judge's competence. Procedural requirements and the judge's assessment of an expert's conclusions provide control guarantees to ensure the reliability of scientific expertise. Experts are obligated to follow objective and rigorous investigation processes, with a professional duty to accuracy and logical approaches. This article examines how judges can control the scientific rigor of experts’ approaches.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2024 188","pages":"Pages 87-95"},"PeriodicalIF":0.1,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141713638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medecine & DroitPub Date : 2024-06-01DOI: 10.1016/j.meddro.2024.02.001
Cécile Manaouil , Sylvain Chamot , Pascal Petit
{"title":"Le médecin confronté à l’IA (Intelligence artificielle) : Éthique et responsabilité","authors":"Cécile Manaouil , Sylvain Chamot , Pascal Petit","doi":"10.1016/j.meddro.2024.02.001","DOIUrl":"10.1016/j.meddro.2024.02.001","url":null,"abstract":"<div><p>Artificial intelligence (AI) is developing at an impressive speed in the field of health. AI paves the way for new practices in diagnostic assistance, preventive medicine, individualized patient follow-up, support in choosing a therapy, assistance in interpreting the results of additional examinations, etc. Far from being a magic bullet, delegating tasks to AI raises many ethical questions relating in particular to the supervision of algorithms, equal access to innovation and the use of patient data. It is still difficult to predict whether AI will remain a “safety net” for the doctor or if it will supplant him. France and Europe have laid down the principle of “human guarantee” in the interpretation of diagnostic and therapeutic results, implying that the machine cannot act alone and enshrining the responsibility of the health professional. This article aims to understand how complex AI is to regulate legally at the risk of neglecting its secrecy, whether at the individual or collective level.</p></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2024 186","pages":"Pages 50-66"},"PeriodicalIF":0.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140276393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medecine & DroitPub Date : 2024-06-01DOI: 10.1016/j.meddro.2024.03.001
Pierre Jouannet (Biologiste de la reproduction et professeur émérite à l’université Paris Cité, Membre de l’Académie nationale de médecine)
{"title":"Fécondation in vitro : quel impact sur la santé à moyen et long terme des enfants conçus","authors":"Pierre Jouannet (Biologiste de la reproduction et professeur émérite à l’université Paris Cité, Membre de l’Académie nationale de médecine)","doi":"10.1016/j.meddro.2024.03.001","DOIUrl":"https://doi.org/10.1016/j.meddro.2024.03.001","url":null,"abstract":"<div><p>Among the medical, scientific and ethical questions raised by in vitro fertilization (IVF), those concerning the medium and long-term health of children and young adults thus conceived are essential. Forty-five years after the birth of the first child and while more than 8 million people in the world have been conceived by IVF, the National Academy of Medicine has devoted a report to this theme, mainly analysing the results of numerous international studies. The published results are rather reassuring but they are not always consistent and many uncertainties remain. The Academy of Medicine calls for further epidemiological and clinical studies in better characterized populations and at later ages of life. The Academy also recommends developing basic research to better explain the potential effects of IVF.</p></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2024 186","pages":"Pages 47-49"},"PeriodicalIF":0.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1246739124000101/pdfft?md5=6e835cf90f5669f45f62c9c0f88ead47&pid=1-s2.0-S1246739124000101-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141250038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medecine & DroitPub Date : 2024-05-29DOI: 10.1016/j.meddro.2024.05.002
Léa Lepoix (doctorante contractuelle)
{"title":"La prise en compte du consentement dans les lois d’interdiction des thérapies de conversion sexuelle","authors":"Léa Lepoix (doctorante contractuelle)","doi":"10.1016/j.meddro.2024.05.002","DOIUrl":"10.1016/j.meddro.2024.05.002","url":null,"abstract":"<div><div>Conversion therapies are pseudo-scientific practices aimed at changing sexual orientation or gender identity using violent methods. Since January 31, 2022, French law has expressly prohibited the practice of conversion therapy. All the difficulty in legislating on this subject tends to not affect the right of individuals to benefit from sexual reassignment operations, which although modifying the identity of people, an intervention whose medical justifications are clearly established.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2024 189","pages":"Pages 103-111"},"PeriodicalIF":0.1,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142707399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medecine & DroitPub Date : 2024-04-01DOI: 10.1016/j.meddro.2023.12.001
Christian Gamaleu Kameni (Enseignant chercheur, Mandataire Judiciaire à la Protection des Majeurs) , Laurent Mortet (Docteur en droit, Avocat au Barreau d’Épinal) , Telesphore Tekebeng Lele (Docteur en droit, Avocat au Barreau d’Épinal)
{"title":"Chronique d’hospitalisation sans consentement","authors":"Christian Gamaleu Kameni (Enseignant chercheur, Mandataire Judiciaire à la Protection des Majeurs) , Laurent Mortet (Docteur en droit, Avocat au Barreau d’Épinal) , Telesphore Tekebeng Lele (Docteur en droit, Avocat au Barreau d’Épinal)","doi":"10.1016/j.meddro.2023.12.001","DOIUrl":"10.1016/j.meddro.2023.12.001","url":null,"abstract":"<div><p>The column on hospitalization psychiatric or hospitalization without consent analyses main decisions of the Court concerning the privation of fundamental rights and freedoms of psychiatric patient. This column will cover main decisions from September to December 2022.</p></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2024 185","pages":"Pages 31-36"},"PeriodicalIF":0.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140279313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medecine & DroitPub Date : 2024-04-01DOI: 10.1016/j.meddro.2023.12.002
Julia Brunn (doctorante en droit privé, secrétaire de rédaction de la Revue Droit & Santé, École de Droit de la Santé) , Pierre-Henri Bréchat (docteur en droit public, docteur ès sciences et habilité à diriger des recherches, membre de l’Institut Droit et Santé, membre associé du Centre d’études et de recherches de sciences administratives et politiques (CERSA), médecin spécialiste de santé publique et médecine sociale, praticien hospitalier, Fellow et diplômé de l’Advanced Training Program (ATP) in Health Care Delivery Improvement de l’Healthcare Delivery Institute, diplômé du Developing Trusted Leaders de l’Intermountain Healthcare Leadership Institute du Kem C. Gardner Transformation Center d’Intermountain Health aux États-Unis d’Amérique)
{"title":"L’humain, la faune sauvage et la chasse : perspectives d’un système intégral de surveillance de la santé","authors":"Julia Brunn (doctorante en droit privé, secrétaire de rédaction de la Revue Droit & Santé, École de Droit de la Santé) , Pierre-Henri Bréchat (docteur en droit public, docteur ès sciences et habilité à diriger des recherches, membre de l’Institut Droit et Santé, membre associé du Centre d’études et de recherches de sciences administratives et politiques (CERSA), médecin spécialiste de santé publique et médecine sociale, praticien hospitalier, Fellow et diplômé de l’Advanced Training Program (ATP) in Health Care Delivery Improvement de l’Healthcare Delivery Institute, diplômé du Developing Trusted Leaders de l’Intermountain Healthcare Leadership Institute du Kem C. Gardner Transformation Center d’Intermountain Health aux États-Unis d’Amérique)","doi":"10.1016/j.meddro.2023.12.002","DOIUrl":"10.1016/j.meddro.2023.12.002","url":null,"abstract":"<div><p>It is important to combat diseases of animal origin, particularly in the light of climatic and environmental disturbances, which can have an impact on human health and the survival of species. There are various human and animal health surveillance systems at global, European and French. Within these systems, wild animals, although an essential element in the transmission of diseases, occupy only a marginal place in France. Monitoring wildlife health is primarily the responsibility of hunters. Their surveillance, data collection and warning systems lack links with human health surveillance systems. From foreign examples, this article suggests a number of ways in which wildlife surveillance systems can be better integrated into human health surveillance systems, with a view to building comprehensive surveillance and warning systems capable of responding more effectively to epidemic risks linked to the rapid transformation of our ecosystems.</p></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2024 185","pages":"Pages 37-46"},"PeriodicalIF":0.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139890827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medecine & DroitPub Date : 2024-04-01DOI: 10.1016/j.meddro.2023.10.001
Quentin Le Pluard (Docteur en Droit de l’université de Brest, membre du Lab-LEX (UR 7480), Enseignant-chercheur contractuel à l’université de Tour)
{"title":"Scolie sur l’évolution du droit médical érotique : Des maladies vénériennes aux remèdes aphrodisiaques, « iatrique ou pas ? »","authors":"Quentin Le Pluard (Docteur en Droit de l’université de Brest, membre du Lab-LEX (UR 7480), Enseignant-chercheur contractuel à l’université de Tour)","doi":"10.1016/j.meddro.2023.10.001","DOIUrl":"10.1016/j.meddro.2023.10.001","url":null,"abstract":"<div><p>Analyse the doctor's role relative to diseases formerly qualified as venereal on the one hand, to aphrodisiac remedies on the other, reveals the existing tension between the care of the social body and the human body, between public and individual health. The evolution of the medical law relating to carnal love demonstrates a significant evolution in this area. By redefining iatric activities, in other words those that come under the art of the doctor, it questions the definition of medicine itself.</p></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2024 185","pages":"Pages 23-30"},"PeriodicalIF":0.2,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135614848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medecine & DroitPub Date : 2024-03-15DOI: 10.1016/j.meddro.2024.02.003
{"title":"La cour de cassation interdit les expertises psychiatriques à distance : l’enfer est toujours pavé de bonnes intentions","authors":"","doi":"10.1016/j.meddro.2024.02.003","DOIUrl":"10.1016/j.meddro.2024.02.003","url":null,"abstract":"<div><div>A recent judgment handed down by the Court of Cassation prohibits the use of telecommunications means to carry out psychiatric assessments. This ban can be welcomed in that it makes it possible to offer quality expertise throughout France, but on the contrary, it arouses fear given the low number of experts and their uniform distribution across the territory.</div></div>","PeriodicalId":41275,"journal":{"name":"Medecine & Droit","volume":"2024 188","pages":"Pages 96-97"},"PeriodicalIF":0.1,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140283600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}